XML 19 R9.htm IDEA: XBRL DOCUMENT v3.4.0.3
4. STOCK-BASED COMPENSATION
9 Months Ended
Mar. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
STOCK-BASED COMPENSATION

Stock-based compensation costs recognized during the quarters ended March 31, 2016 and 2015 amounted to $51,705 and $2,625 respectively, and the costs were included in the accompanying consolidated statements of operations in: selling, general and administrative expenses (2016 - $33,721; 2015 - $0), research and development expenses (2016 - $9,316; 2015 - $2,625) and cost of goods sold (2016 - $8,668; 2015 - $0). Stock-based compensation costs recognized during  the nine month periods ended March 31, 2016 and 2015 amounted to $194,133 and $42,750, respectively, and were included in the accompanying consolidated statements of operations in: selling, general and administrative expenses (2016 - $94,099; 2015 - $27,000), research and development expenses (2016 - $48,023, 2015 - $15,750) and cost of goods sold (2016 - $52,011, 2015 - $0). No compensation has been capitalized because such amounts would have been immaterial.

 

The following tables summarize stock option activity for the nine months ended March 31, 2016:

 

    Options Outstanding  
    Number of
Shares
    Weighted Average
Exercise Price
    Weighted Average
Contractual Life
 
Outstanding at June 30, 2015     1,079,079     $    1.43       8.46 years  
Grants     60,000       0.48          
Cancellations     (3,800)     $ 3.00          
Outstanding at March 31, 2016     1,135,279     $ 1.37       7.83 years  

   

Information related to the stock options outstanding as of March 31, 2016 is as follows:

 

Range of Exercise Prices   Number of Shares   Weighted-Average Remaining Contractual Life (years)   Weighted-Average Exercise Price   Exercisable Number of Shares   Exercisable Weighted-Average Exercise Price 
$0.48    60,000    10.00   $         0.48    20,000   $         0.48 
$0.73    316,000    9.14   $0.73    165,000   $0.73 
$0.73    330,000    9.14   $0.73    132,915   $0.73 
$0.90    35,000    8.28   $0.90    23,334   $0.90 
$0.90    30,000    8.28   $0.90    30,000   $0.90 
$1.20    207,800    5.92   $1.20    207,800   $1.20 
$0.90    9,000    7.76   $0.90    9,000   $0.90 
$0.85    9,000    6.76   $0.85    9,000   $0.85 
$0.55    44,000    5.92   $0.55    44,000   $0.55 
$0.27    40,000    5.29   $0.27    40,000   $0.27 
$1.35    1,200    3.65   $1.35    1,200   $1.35 
$1.25    1,200    2.65   $1.25    1,200   $1.25 
$6.25    1,600    0.66   $6.25    1,600   $6.25 
$7.75    1,200    1.66   $7.75    1,200   $7.75 
$13.75    49,279    0.11   $13.75    49,279   $13.75 
$0.27–$13.75    1,135,279    7.83   $1.37    735,528   $1.73 

 

The aggregate intrinsic value of the Company’s “in-the-money” outstanding and exercisable options as of March 31, 2016 was $8,400.